Foundayo is an FDA-approved, once-daily prescription pill for chronic weight management. It is not currently available for initial purchase through SkinnyRx.
What it is
Foundayo contains orforglipron, an oral GLP-1 medication. It may be prescribed for adults with obesity, or adults with overweight and at least one weight-related condition. Your provider will review your health information and decide if it is appropriate for you.
Foundayo may help reduce appetite and cravings. It also slows digestion, which may help you feel full longer. It may support blood sugar control and metabolic health. Results vary from person to person.
Access to branded medications uses the SkinnyRx Membership. The membership covers clinical review, prescription coordination, and ongoing support. The medication is billed and fulfilled separately. Learn more in What is the SkinnyRx Membership for branded medications?.
SkinnyRx is not affiliated with or endorsed by Eli Lilly & Co., the owner of the registered trademark Foundayo.
How to take it
Take Foundayo once a day. You may take it at any time of day, with or without food. Follow the instructions from your provider.
Your provider decides your dose and any medication changes. If you have questions about your dose, use the chat in the SkinnyRx app to ask your provider. Do not change how you take it on your own.
Ask your care team what to do if you miss a dose.
Storage
Foundayo does not need refrigeration or special storage. Ask your care team if you have questions about where to keep it or whether it was exposed to unusual conditions.
Common side effects
Ask your care team about possible side effects before taking Foundayo. If you develop side effects, use the chat in the SkinnyRx app for guidance.
When to contact your care team
Contact your care team if you have side effects, safety concerns, or questions about whether Foundayo is right for you. Your provider can review your symptoms and treatment.
Important safety information
Foundayo causes thyroid C-cell tumors in rats. Do not use Foundayo if you or anyone in your family has ever had medullary thyroid carcinoma, also called MTC, or Multiple Endocrine Neoplasia syndrome type 2, also called MEN 2.
GLP-1 medications, including Foundayo, are not recommended during pregnancy or breastfeeding. If you become pregnant during treatment, stop taking your medication right away and tell your care team. If you are breastfeeding or planning a pregnancy, tell your provider before starting or continuing treatment.
Need more help?
Contact the support team. See How do I contact support?.